CAR-engineered NK cells are outstanding to Vehicle-T cells; they look like safer because they usually do not induce cytokine release syndrome (CRS) and they interact many mechanisms to market cytotoxicity188. Additionally they lend themselves to ‘off-the shelf’ manufacturing, that is, they are often produced from peripheral blood cells or from